Articles by Nancy F. Woods, PhD : Menopause

Articles by Nancy F. Woods, PhD

Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study

Harrington, Laura B.; Weiss, Noel S.; Wiggins, Kerri L.; More

Menopause. 23(2):143-149, February 2016.

Menopause, symptom clusters, and the complexity of women's lives

Woods, Nancy F.

Menopause. 22(11):1153-1154, November 2015.

PDF
Permissions

Sleep and menopause: a narrative review

Shaver, Joan L.; Woods, Nancy F.

Menopause. 22(8):899-915, August 2015.

Hot flashes across the life span: adjusting the lens

Woods, Nancy F.

Menopause. 22(4):365-366, April 2015.

PDF
Permissions

Assessing menopause-specific quality of life in studies of the menopausal transition and early postmenopause

Woods, Nancy F.

Menopause. 21(8):792-793, August 2014.

PDF
Permissions

Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial

Chlebowski, Rowan T.; Cirillo, Dominic J.; Eaton, Charles B.; More

Menopause. 20(6):600-608, June 2013.

Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial

Ensrud, Kristine E.; Joffe, Hadine; Guthrie, Katherine A.; More

Menopause: The Journal of The North American Menopause Society. 19(8):848-855, August 2012.

Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial

Tom, Sarah E.; Anderson, Melissa L.; Landis, Carol A.; More

Menopause. 18(11):1184-1190, November 2011.

Vasomotor symptoms and coronary artery calcium in postmenopausal women

Allison, Matthew A.; Manson, JoAnn E.; Aragaki, Aaron; More

Menopause. 17(6):1136-1145, November-December 2010.

Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial

Brunner, Robert L.; Aragaki, Aaron; Barnabei, Vanessa; More

Menopause. 17(5):946-954, September-October 2010.

Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial

Michael, Yvonne L.; Gold, Rachel; Manson, JoAnn E.; More

Menopause. 17(2):295-302, March 2010.

"Persistence" improves the 60-day amenorrhea marker of entry to late-stage menopausal transition for women aged 40 to 44 years

Taffe, John R.; Cain, Kevin C.; Mitchell, Ellen S.; More

Menopause. 17(1):191-193, January 2010.

Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition

Mitchell, Ellen S.; Farin, Frederico M.; Stapleton, Patricia L.; More

Menopause. 15(1):105-111, January 2008.

Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study

Woods, Nancy F.; Mitchell, Ellen Sullivan; Tao, Yun; More

Menopause. 13(6):902-910, November-December 2006.

Increased urinary cortisol levels during the menopause transition

Woods, Nancy F.; Carr, Molly C.; Tao, Eunice Y.; More

Menopause. 13(2):212-221, March-April 2006.

Letters to the Editor: In reply

Soules, Michael R.; Parrott, Estella; Rebar, Robert; More

Menopause. 9(6):464-465, November 2002.

Permissions

Bone Resorption Levels by Age and Menopausal Status in 5,157 Women

Lewis, Linda L.; Shaver, Joan F.; Woods, Nancy F.; More

Menopause. 7(1):42-52, 2000.

Secondary Logo

Journal Logo